Know Cancer

or
forgot password

A Randomized, Double-Blind, Multi-center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma


Phase 2
16 Years
N/A
Not Enrolling
Both
Melanoma

Thank you

Trial Information

A Randomized, Double-Blind, Multi-center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma


Inclusion Criteria:



- Patients with previously treated, therapy-refractory or -intolerant, Stage III
(unresectable) or Stage IV melanoma

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Outcome Measure:

estimate BORR in patients with previously treated, therapy-refractory or -intolerant, Stage III (unresectable) or Stage IV melanoma receiving ipilimumab doses of 0.3, 3, and 10 mg/kg.

Authority:

United States: Food and Drug Administration

Study ID:

CA184-022

NCT ID:

NCT00289640

Start Date:

April 2006

Completion Date:

July 2007

Related Keywords:

  • Melanoma
  • Stage III (unresectable)
  • Stage IV melanoma
  • Melanoma

Name

Location

Arizona Cancer Center Tucson, Arizona  85724
Memorial Sloan Kettering Cancer Center New York, New York  10021
Washington University School of Medicine Saint Louis, Missouri  63110
MD Anderson Cancer Center Orlando Orlando, Florida  32806
Hubert H. Humphrey Cancer Center Coon Rapids, Minnesota  55433
Cancer Centers of the Carolinas Greenville, South Carolina  29605
Mount Sinai Comprehensive Cancer Center Miami Beach, Florida  33140
Ellis Fischel Cancer Center Columbia, Missouri  65203
Palm Beach Cancer Institute West Palm Beach, Florida  33401
Presbyterian Hospital Charlotte, North Carolina  28233-3549
Mary Crowley Medical Research Center Dallas, Texas  75246
Scripps Cancer Center La Jolla, California  92037
Cleveland Clinic Cleveland, Ohio  44195
Oncology Specialists, SC Park Ridge, Illinois  60068
Providence Portland Medical Center Portland, Oregon  97213-3635
University of Louisville Louisville, Kentucky  40202
Yale University School Of Medicine New Haven, Connecticut  06520
Baptist Cancer Institute Jacksonville, Florida  32207
The Angeles Clinic And Research Institution Santa Monica, California  90404
St Joseph Oncology Inc St Joseph, Missouri  64507
The Christ Hospital Cancer Center Research Cincinnati, Ohio  45219
Wilshire Oncology Medical Group Inc Laverne, California  91750
American Health Network Indianapolis, Indiana  46202
Harry And Jeanette Weinberg Cancer Inst At Franklin Square Baltimore, Maryland  21237
Center For Oncology Research & Treatment, P.A. Dallas, Texas  75230